Citigroup Inc. Depositary Shares, each representing a 1/1,000th interest in a share of 6.300% Noncum
C.PRS
C.PRS was delisted on the 11th of February, 2021.
7 hedge funds and large institutions have $3.8M invested in Citigroup Inc. Depositary Shares, each representing a 1/1,000th interest in a share of 6.300% Noncum in 2017 Q1 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 0 closing their positions.
0% more funds holding
Funds holding: 7 → 7 (0)
2% less capital invested
Capital invested by funds: $3.88M → $3.8M (-$82.3K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CC
Colrain Capital
Boston,
Massachusetts
|
-$237K |
C.PRS Hedge Fund Activity: Q1 2017 in Review
7 of the 4,018 institutional investors tracked by Wall St. Rank reported a position in Citigroup Inc. Depositary Shares, each representing a 1/1,000th interest in a share of 6.300% Noncum (C.PRS) for Q1 2017, worth a combined $3.8M — down 2.1% from $3.88M a quarter earlier.
Fund positioning in C.PRS was balanced in Q1 2017: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 1 trimmed.
The largest seller was Colrain Capital, cutting an estimated $237K.
- 7 institutional investors held Citigroup Inc. Depositary Shares, each representing a 1/1,000th interest in a share of 6.300% Noncum (C.PRS) as of Q1 2017, unchanged from Q4 2016.
- Funds reported $3.8M of Citigroup Inc. Depositary Shares, each representing a 1/1,000th interest in a share of 6.300% Noncum stock for Q1 2017, down 2.1% quarter-over-quarter.
- 0 funds opened new Citigroup Inc. Depositary Shares, each representing a 1/1,000th interest in a share of 6.300% Noncum positions in Q1 2017 and 0 closed out.
- The largest Citigroup Inc. Depositary Shares, each representing a 1/1,000th interest in a share of 6.300% Noncum seller in Q1 2017 was Colrain Capital, an estimated $237K sold.
Based on aggregated 13F filings for Q1 2017.